Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04220970

Enrollment

150

Registered

2020-01-07

Start date

2017-06-07

Completion date

2032-06-07

Last updated

2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)

Keywords

BIA-ALCL

Brief summary

Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant. Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a BIA-ALCL case registry, in connection with a national Multidisciplinary meeting (Réunion de Concertation Pluridisciplinaire nationale de recours- RCP). This registry is opened in France and in Belgium

Interventions

OTHERBIA-ALCL

Observational : no intervention

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patients with an anaplastic large cell lymphoma associated with breast implants

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
Overall response	13 years

Countries

Belgium, France

Contacts

Primary ContactManon Croix

manon.croix.ext@lysarc.org+33 (04) 72 66 93 33

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026